Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 5.4. It has been cited 206 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.800
From this paper's citation signal
Citation Network Contribution
4.6
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Bill and Melinda Gates Foundation
Grant: OPP1209843
Agence Nationale de la Recherche
Grant: ANR-11-15 LABX-0024-PARAFRAP
Programme IdEX 2022
Grant: Attractivité - Dotation d’accueil des professeurs
National Institutes of Health
Grant: R01 AI109023
World Health Organization
Grant: 001
National Institutes of Health
Grant: 1R01AI109023-01A1
Defining P. falciparum resistance to artemisinin-based combination therapies
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
Additional file 1 of Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
Additional file 2 of Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
Additional file 2 of Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
Additional file 1 of Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Additional file 1 of Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Additional file 1 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 1 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 2 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 2 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 3 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 3 of Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Additional file 1 of Leucinostatins from fungal extracts block malaria transmission to mosquitoes
Additional file 1 of Leucinostatins from fungal extracts block malaria transmission to mosquitoes